Intended Audience:
This program is intended for interventional cardiologists, as well as physician specialists who manage patients in the emergency department, coronary care unit, and cardiac catheterization laboratory.
Registration:
Enrollment for this webcast is complimentary, and clinicians are invited to attend this CME-certified symposium and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
Grantor Support:
Supported by an independent educational grant from The Medicines Company, Inc.
Accreditation Statement for Jointly-Sponsored Programs:
This activity has been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education
through the joint sponsorship of The University of Massachusetts Medical School
and CMEducation Resources, LLC. The University of Massachusetts Medical School
is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement:
The University of Massachusetts Medical School designates this educational activity
for a maximum of 3 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit
commensurate with the extent of their participation in the activity.
Policy on Faculty and Provider Disclosure:
It is the policy of the University of Massachusetts Medical School to ensure fair
balance, independence, objectivity and scientific rigor in all activities. All
faculty participating in CME activities sponsored by the University of Massachusetts
Medical School are required to present evidence-based data, identify and reference
off-label product use and disclose all relevant financial relationships with those
supporting the activity or others whose products or services are discussed. Faculty
disclosure will be provided in the activity materials.
Faculty Disclosures
Jeffrey J. Popma, MD, FSCAI
Research grant support from Cordis, Guidant, Boston Scientific, Medtronic, Abbott Vascular, Inc., Radiant Medical, Pharmasonics, Pharmacylics, Embolic Protection, Inc, and MedNova.
Advisory board: Pfizer and Cordis
Speakers bureau: Pfizer, Cor-Millenium, Schering-Plough, and Boston-Scientific.
Gary L. Schaer, MD FACC, FSCAI
Consultant: Sanofi-Aventis
Speaker’s Bureau: Sanofi-Aventis, The Medicines Company
Sunil V. Rao, MD
Consultant: Sanofi-Aventis, The Medicines Company
Speaker’s Bureau: Sanofi-Aventis, The Medicines Company, Pfizer
Steven V. Manoukian, MD, FACC
Consultant: The Medicines Company
Speaker’s Bureau: The Medicines Company
Program Faculty
Jeffery
J. Popma
, MD, FSCAI
(Program Chairman)
Associate Professor of Medicine
Harvard Medical School
Director of the Angiographic Core Laboratory
Brigham and Women's Hospital
Boston, MA
Gary
L. Schaer
, MD, FSCAI
Professor of Medicine
Director, Cardiac Cath Labs
Rush University Medical Center
Chicago, IL
Sunil
V. Rao
, MD
Assistant Professor of Medicine
Duke University Medical Center
Director, Cardiac Catheterization Laboratories
Durham VA Medical Center
Durham, NC
Steven
V. Manoukian
, MD, FACC
Director, Interventional Cardiology
Emory-Crawford Long Hospital
Emory University School of Medicine
President, American Heart Association
Atlanta Division
Atlanta, GA
Educational Objectives:
-
Interventional cardiologists will learn to risk stratify patients with ischemic coronary syndromes and identify optimal antithrombotic therapy for those undergoing PCI
-
Interventional cardiologists will learn evidence-based approaches to reducing bleeding complications and risk of transfusion in patients undergoing PCI
-
Clinicians will learn how to select antithrombotic agents to balance reduction of ischemic complications with reduction in bleeding complications
-
Clinicians will learn how to prevent and assess heparin-induced thrombocytopenia in patients undergoing PCI
-
Clinicians will learn how landmark trials and analyses focusing on PCI and ACS can assist in guiding antithrombotic therapy in the contemporary setting of invasive management of ACS
Copyright (c) 2006 All rights reserved including
